New scanner aims to cut repeat breast cancer surgeries
NCT ID NCT07341542
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study will test a device called the Histolog Scanner in 20 women having breast-conserving surgery for breast cancer. The scanner uses special microscopy to check if all cancer has been removed while the patient is still in the operating room. The goal is to see if this can reduce the number of women who need a second surgery because cancer cells were left behind. The study is observational and does not change standard care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Histolog scanner (device)
What this could lead to
If successful, this scanner could help surgeons remove all cancer in one operation, reducing the need for a second surgery.
What could go wrong
This is a very small pilot study with only 20 patients, so results may not apply to everyone. The scanner is still experimental and not yet proven to reduce reoperations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Silesian Hospital in Opava
Opava, Czechia